Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H8BrN4O3.Na |
| Molecular Weight | 371.121 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].BrC1=CC=C(C=C1)C2=CN=C(O2)\C=N\N3CC(=O)[N-]C3=O
InChI
InChIKey=PHJRJPWBPXLNAJ-FPUQOWELSA-M
InChI=1S/C13H9BrN4O3.Na/c14-9-3-1-8(2-4-9)10-5-15-12(21-10)6-16-18-7-11(19)17-13(18)20;/h1-6H,7H2,(H,17,19,20);/q;+1/p-1/b16-6+;
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C13H9BrN4O3 |
| Molecular Weight | 349.14 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Azumolene is a direct-acting, skeletal muscle relaxant with structural similarities to dantrolene. It is a muscle relaxant that inhibits the release of calcium from skeletal muscle sarcoplasmic reticulum. Azumolene inhibits a component of store-operated calcium entry (SOCE) coupled to activation of type 1 ryanodine receptor (RyR1) by caffeine and ryanodine, whereas the SOCE component induced by thapsigargin is not affected. Azumolene distinguishes between two mechanisms of cellular signaling to SOCE in skeletal muscle, one that is coupled to and one independent from RyR1. Azumolene is equipotent to dantrolene sodium in blocking pharmacologic-induced muscle contractures and that azumolene is efficacious for treatment/prevention of malignant hyperthermia.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Component of store-operated calcium entry Sources: https://www.ncbi.nlm.nih.gov/pubmed/16945924 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:35:09 GMT 2025
by
admin
on
Mon Mar 31 21:35:09 GMT 2025
|
| Record UNII |
00N857K16Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
143169
Created by
admin on Mon Mar 31 21:35:09 GMT 2025 , Edited by admin on Mon Mar 31 21:35:09 GMT 2025
|
PRIMARY | |||
|
00N857K16Y
Created by
admin on Mon Mar 31 21:35:09 GMT 2025 , Edited by admin on Mon Mar 31 21:35:09 GMT 2025
|
PRIMARY | |||
|
13724090
Created by
admin on Mon Mar 31 21:35:09 GMT 2025 , Edited by admin on Mon Mar 31 21:35:09 GMT 2025
|
PRIMARY | |||
|
105336-14-9
Created by
admin on Mon Mar 31 21:35:09 GMT 2025 , Edited by admin on Mon Mar 31 21:35:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |